Cyclophosphamide in the male rat: new pattern of anomalies in the third generation.
Several abnormalities, such as postnatal deaths and behavioral impairments, have been previously reported in the progeny of male rats exposed to the cytostatic drug cyclophosphamide 60 days prior to mating. The anomalies were transmitted to the second generation (F2). The present results concern the third generation. Two experimental groups have been studied: a hybrid group, resulting from crosses between control subjects and either experimental F2 males or females, and a nonhybrid group, obtained by mating experimental F2 subjects together. Significant abnormalities were found in all experimental groups, whether the F2 subjects were male or female. F2 females had smaller litters whether they were mated with control or experimental males. Body weight was significantly increased in both hybrid and nonhybrid males. Increased postnatal mortality and learning deficit were also observed in the hybrid group. Such complex phenotypic changes confirm that frequent mutations probably have been inherited from the treated males but also suggest that genetic rearrangements have occurred from one generation to the next.
Laboratoire d'Histologie-Embryologie-Cytogénétique, CHU Bicetre, France.
E J
EJ
Dulioust
N Y
NY
Nawar
S G
SG
Yacoub
A B
AB
Ebel
E H
EH
Kempf
M R
MR
Auroux
D000014:Abnormalities, Drug-Induced / Q000473:pathology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003520:Cyclophosphamide / Q000633:toxicity*; D005298:Fertility / Q000187:drug effects; D006824:Hybridization, Genetic / Q000187:drug effects; D008297:Male; D010641:Phenotype; D051381:Rats; D011919:Rats, Inbred Strains; D012098:Reproduction / Q000187:drug effects
D003520:Cyclophosphamide